New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2014
08:10 EDTBSPMBiostar Pharmaceuticals enters into securities purchase agreement
Biostar Pharmaceuticals announced that it entered into a securities purchase agreement with certain institutional investors for the sale of 1,650,000 shares of common stock in a registered direct offering at the price of $2.49 per share. In addition, warrants to purchase 660K shares of common stock in the aggregate will be issued to the investors. The warrants will be exercisable immediately upon issuance at an exercise price of $3.23 per share and expire three years from the date of issuance. Gross proceeds of the offering, before deducting placement agent fees and other estimated offering expenses payable by the company, are expected to be approximately $4..1M. The net proceeds from this offering will be used for working capital and other general corporate purposes. The completion of the offering will occur on or before March 13.
News For BSPM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 18, 2014
08:22 EDTBSPMBiostar Pharmaceuticals files patent application for oleanolic acid injection
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use